Roper Technologies
ROP
358.57
-3.71
-1.02%
Roper Technologies
US · ROP
#609 by market cap
Listed 1970
358.57
-3.71
-1.02%
Live - 5344 symbols - heartbeat 8s ago
· 2026-10-08 04:00
Pre-market
358.57
0.00%
After-hours
358.57
0.00%
Overnight
358.64
+0.02%
- Market cap
- 35.46B
- P/E (TTM)i
- 14.94
- P/Bi
- 1.90
- EPSi
- 14.20
- Div yieldi
- 0.97%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on ROP?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
453.25 +26.4%
Price target rangecurrent 358.57
Low335.00
Avg453.25
High550.00
Buy 60%
Hold 30%
Sell 10%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-08 | William Blair | -- | BUY | -- |
| 2026-08-17 | RBC Capital | -- | HOLD | 417.00 |
| 2026-08-05 | Argus Research | -- | BUY | 450.00 |
| 2026-07-27 | Truist Financial | -- | BUY | 475.00 |
| 2026-07-24 | TD Cowen | -- | BUY | 550.00 |
| 2026-07-24 | Piper Sandler | -- | BUY | 526.00 |
| 2026-07-24 | Truist Financial | -- | BUY | 475.00 |
| 2026-07-24 | Baird | -- | BUY | 480.00 |
| 2026-07-23 | William Blair | -- | BUY | -- |
| 2026-07-23 | BMO Capital | -- | HOLD | 393.00 |
| 2026-07-23 | RBC Capital | -- | HOLD | 417.00 |
| 2026-07-22 | Raymond James | -- | HOLD | -- |
| 2026-07-21 | Mizuho Securities | -- | SELL | 335.00 |
| 2026-07-10 | BMO Capital | -- | HOLD | 393.00 |
| 2026-06-24 | Citi | -- | BUY | 450.00 |
| 2026-06-17 | Oppenheimer | -- | HOLD | -- |
| 2026-05-07 | Truist Financial | -- | BUY | -- |
| 2026-04-27 | Truist Financial | -- | BUY | 475.00 |
| 2026-04-24 | TD Cowen | -- | BUY | 550.00 |
| 2026-04-24 | Piper Sandler | -- | BUY | 540.00 |
| 2026-04-24 | Truist Financial | -- | BUY | 475.00 |
| 2026-04-24 | Baird | -- | BUY | 470.00 |
| 2026-04-24 | Oppenheimer | -- | HOLD | -- |
| 2026-04-23 | William Blair | -- | BUY | -- |
| 2026-04-23 | Truist Financial | -- | BUY | -- |
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
1 4
■ Upgrades■ Downgrades
- 1 upgrade vs 4 downgrades among tracked analyst rating changes.
- The single most recent change was actually an upgrade (Argus Research moved from Hold to Buy on 2026-08-05), though the broader window skews toward downgrades.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-05 | Argus Research | HOLD → BUY | 450.00 |
| 2026-07-22 | Raymond James | BUY → HOLD | -- |
| 2026-01-27 | Oppenheimer | BUY → HOLD | -- |
| 2026-01-05 | Mizuho Securities | HOLD → SELL | 419.00 |
| 2025-10-26 | RBC Capital | BUY → HOLD | 539.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | -- | ±8.09% | +5.47% (in line) |
| 2026/Q1 | 2026-04-23 | -- | ±6.23% | -0.27% (in line) |
| 2025/Q4 | 2026-01-27 | -- | ±5.02% | -9.64% (beat) |
| 2025/Q3 | 2025-10-23 | -- | ±4.89% | -5.70% (beat) |
| 2025/Q2 | 2025-07-21 | -- | ±5.09% | +1.31% (in line) |
| 2025/Q1 | 2025-04-28 | -- | ±5.71% | -1.03% (in line) |
| 2024/Q4 | 2025-01-30 | -- | ±4.84% | +5.08% (beat) |
| 2024/Q3 | 2024-10-23 | -- | ±5.57% | -1.66% (in line) |
| 2024/Q2 | 2024-07-24 | -- | ±5.24% | -7.37% (beat) |
| 2024/Q1 | 2024-04-26 | -- | ±4.65% | -2.52% (in line) |
| 2023/Q4 | 2024-01-31 | -- | ±4.37% | -4.38% (beat) |
| 2023/Q3 | 2023-10-25 | -- | ±5.50% | -0.28% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:00:01 · For reference only, not investment advice and not tailored to your situation.